Sinha Vikas

Chief Financial Officer | See Remarks

2 companies

Excellent

Trades Analyzed

12M Win Rate

97.4%

Avg 3M Return

+19.2%

Avg 12M Return

+60.5%

Sinha Vikas is a Chief Financial Officer at SRRK with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $27.8M based on current market prices.

Holdings by Company

SRRKJan 13, 2026

Current Shares583.2K

Value$27.60M

Net Activity-16,755

Bought: 0Sold: 16.8K

KLRSFeb 21, 2025

Current Shares49.1K

Value$231.9K

Net Activity-106,402

Bought: 0Sold: 106.4K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 17, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	2,490	$1.63	$4,061.44	-0.2%	-57.7%	-65.1%
Oct 20, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	2,707	$1.56	$4,219.54	-0.1%	-54.3%	-48.8%
Oct 3, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	755	$1.98	$1,492.11	-	-66.4%	-59.8%
Aug 17, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	10,516	$2.50	$26,242.68	-0.9%	-32.0%	-69.9%
Jul 20, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	2,635	$3.44	$9,076.89	-0.1%	-51.4%	-77.5%
Jul 5, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	2,983	$3.05	$9,083.53	-0.3%	-35.7%	-78.1%
Apr 20, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	2,683	$3.66	$9,828.47	-0.1%	-10.1%	-80.2%
Jan 20, 2023	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	6,537	$5.09	$33,287.18	-0.3%	-28.0%	-87.0%
Oct 19, 2022	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	1,449	$9.36	$13,563.65	-0.1%	-40.8%	-83.6%
Jul 20, 2022	KLRS Kalaris Therapeutics, Inc.	See Remarks	Sell	1,432	$5.21	$7,467.16	-0.2%	+87.2%	-37.9%